FDA label
What is Orgovyx used for?
Orgovyx contains relugolix. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “ORGOVYX is indicated for the treatment of adult patients with advanced prostate cancer.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Orgovyx?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Orgovyx, tablet, film coated
Indications and Usage, quoted from the label by Sumitomo Pharma America, Inc. (NDA214621). Cross-references to other label sections are left out.
ORGOVYX is indicated for the treatment of adult patients with advanced prostate cancer.
Source: DailyMed label, set id 077a92f6-9f1b-479a-87c7-c92b5db6aa9c, version 13, effective October 8, 2026. NDC 72974-120, one of 1 listing for this product.
Questions
What is Orgovyx used for?
The FDA label says: “ORGOVYX is indicated for the treatment of adult patients with advanced prostate cancer.”
What drug class is Orgovyx?
FDA lists relugolix in the Gonadotropin Releasing Hormone Receptor Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.